AIDS 2022, the 24th International AIDS Conference, will call on the world to come together to re-engage and follow the science. It will define future research agendas, shift latest evidence to action, and chart a new consensus on overcoming the HIV epidemic as a threat to public health and individual well-being. HVTN researchers and staff are looking forward for the opportunity to learn and connect with colleagues from around the world, as well as presenting recent work.
In addition to the presentations mentioned below, we invite you to come and visit us at our booth in the Global Village. Our location, GVE023, is highlighted in this map (pdf download) for reference.
Immune correlates analysis of the Imbokodo HIV-1 vaccine efficacy trial
Kenny A, Luedtke A, Hyrien O, Fong Y, Burnham R, Heptinstall J, Sawant S, Stanfield-Oakley S, Omar FL, Khuzwayo S, Dintwe O, Borducchi E, Pattacini L, Willems W, Lavreys L, van Duijn J, Stieh DJ, Tomaka F, Pau MG, Gray GE, Buchbinder S, Mngadi K, McElrath MJ, Corey L, Barouch DH, De Rosa SC, Ferrari G, Andersen-Nissen E, Tomaras G, Gilbert PB
High prevalence of asymptomatic Omicron carriage and correlation with CD4+ T-cell count among adults with HIV enrolling in COVPN 3008 Ubuntu clinical trial in sub-Saharan Africa
Tapley A, Andriesen K, Fisher L, Huang Y, Ketter N, Villaran M, Gilbert P, Hural J, Yacovone M, Bekker LG, Corey L, Gray GE, Makhema J, Nuwagaba-Biribonwoha H, Samadari T, Elyanu PJ, Chilengi R, Chirenje Z, Dadabhai S, Mgodi N, Kotze P, Garrett N